NEXT

Law.com

Federal Judge Tosses Plaintiffs' Causation Experts in Acetaminophen ADHD Lawsuits

Kenvue, formerly Johnson & Johnson Consumer, manufacturer of Tylenol, said it planned to move for dismissal of the lawsuits after U.S. District Judge Denise Cote found all five of plaintiffs' general causation experts inadmissible.
3 minute read

Corporate Counsel

Walgreens Legal Chief Departs After CEO Change

Danielle Gray is moving on one year after she helped the drugstore giant resolve opioid litigation by agreeing to pay $5.8 billion over 15 years.
2 minute read

New Jersey Law Journal

The OxyContin Bargain

However 'Harrington v. Purdue Pharma' is decided, the deal leaves a bad taste.
6 minute read

Law.com

Opioid Defendant Moves to Disqualify Motley Rice Over Alleged Ethical Concerns

OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read

New York Law Journal

Consumer-Protection Package Empowers Private Attorneys, AG To Fight Predatory Acts

An attorney for a New York consumer-protection advocacy coalition asked lawmakers to advance a fifth proposal, the Consumer and Small Business Protection Act, which didn't make it out of committee.
3 minute read

New Jersey Law Journal

Merck Hit With Antitrust Suit Over Settlement for 2 Best-Selling Cholesterol Treatments

"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
3 minute read

National Law Journal

Abortion Rights Set to Return to Supreme Court With Mifepristone Case

The Supreme Court, which sought to "return the issue of abortion" to the states back in 2022, is set once again to wade into the battle over reproductive rights by hearing an appeal to reinstate full access to the abortion pill.
5 minute read

The Legal Intelligencer

Ozempic and Wegovy Manufacturers Accused of Downplaying Drugs' Risks in Product Liability Suit

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be first to know about new suits in your region, practice area or client sector.
5 minute read

Law.com

New Lawsuits: Opioid Addiction Medication Suboxone Causes Tooth Loss

Peter Mougey, a lead plaintiffs attorney in the opioid multidistrict litigation, said of Suboxone patients: "Their teeth are falling out of their mouths."
5 minute read

New York Law Journal

Upping the Dosage: Health Care and Pharmaceuticals Antitrust Regulation in 2023

Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
10 minute read

Resources

  • Leveraging Technology to Improve Employee Engagement and Client Satisfaction

    Brought to you by CARET Legal

    Download Now

  • How to Choose Your Legal Operations Software: Key Considerations and Expert Tips

    Brought to you by DiliTrust

    Download Now

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now